Overview

A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects

Status:
Completed

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

This study will determine the effect of food on the pharmacokinetics (PK) of a single dose of 1.5 mg tivozanib in normal healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

AVEO Pharmaceuticals, Inc.